Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing

Inhaled treprostinil was approved recently for interstitial lung disease‐pulmonary hypertension; however, efficacy in “real‐world” populations is not known. We designed a protocol and report our experience evaluating 10 patients referred for therapy. Misdiagnosis at presentation was common; ultimate...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Shelsey W., Finlay, Lauren, Mathai, Stephen C., Goldstein, Ronald H., Maron, Bradley A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450844/
https://www.ncbi.nlm.nih.gov/pubmed/36092795
http://dx.doi.org/10.1002/pul2.12126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450844/
https://www.ncbi.nlm.nih.gov/pubmed/36092795
http://dx.doi.org/10.1002/pul2.12126

Ejemplares similares